We are live on ! Find out more
MBOT icon

Microbot Medical
MBOT

23 hedge funds and large institutions have $3.84M invested in Microbot Medical in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% more capital invested

Capital invested by funds: $3.6M → $3.84M (+$233K)

1.41% more ownership

Funds ownership: 9.88% → 11.3% (+1.4%)

8% less funds holding

Funds holding: 25 → 23 (-2)

17% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 6

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
23
Holders Change
-2
Holders Change %
-8%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
5
Reduced
6
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$18.6K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$6.35K
3
Bank of New York Mellon
Bank of New York Mellon
New York
+$771
4
CAN
Cetera Advisor Networks
California
+$519
5
Wells Fargo
Wells Fargo
California
+$10

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$5.14K
2
SPIA
Steward Partners Investment Advisory
New York
-$5.14K
3
UBS Group
UBS Group
Switzerland
-$5.11K
4
NSIM
North Star Investment Management
Illinois
-$3K
5
BlackRock
BlackRock
New York
-$2.03K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.29M – – –
BlackRock
2
BlackRock
New York
$726K -$2.03K -395 -0.3%
AA
3
AlphaCentric Advisors
Puerto Rico
$478K +$514K +100,000 New
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$442K +$18.6K +3,609 +4%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$253K +$6.35K +1,235 +2%
Morgan Stanley
6
Morgan Stanley
New York
$181K – – –
State Street
7
State Street
Massachusetts
$125K – – –
Renaissance Technologies
8
Renaissance Technologies
New York
$91K -$5.14K -1,000 -5%
Bank of New York Mellon
9
Bank of New York Mellon
New York
$75K +$771 +150 +1%
CAN
10
Cetera Advisor Networks
California
$60K +$519 +101 +0.8%
SPIA
11
Steward Partners Investment Advisory
New York
$51K -$5.14K -1,000 -9%
Northern Trust
12
Northern Trust
Illinois
$50K – – –
TRCT
13
Tower Research Capital (TRC)
New York
$9K -$1.88K -365 -16%
Osaic Holdings
14
Osaic Holdings
Arizona
$4K – – –
UBS Group
15
UBS Group
Switzerland
$3K -$5.11K -993 -62%
Wells Fargo
16
Wells Fargo
California
$1K +$10 +2 +0.8%
NSIM
17
North Star Investment Management
Illinois
– -$3K -650 Closed
Bank of America
18
Bank of America
North Carolina
– -$10 -2 -50%

MBOT Hedge Fund Activity: Q3 2022 in Review

23 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q3 2022, worth a combined $3.84M — up 6.5% from $3.6M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of MBOT and 1 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 5 added.

The largest buyer was Dimensional Fund Advisors, adding an estimated $18.6K. The largest seller was Renaissance Technologies, cutting an estimated $5.14K.

  • 23 institutional investors held Microbot Medical (MBOT) as of Q3 2022, down from 25 in Q2 2022.
  • Funds reported $3.84M of Microbot Medical stock for Q3 2022, up 6.5% quarter-over-quarter.
  • 1 fund opened new Microbot Medical positions in Q3 2022 and 3 closed out, a net change of -2 holders.
  • The largest Microbot Medical buyer in Q3 2022 was Dimensional Fund Advisors, an estimated $18.6K added.
  • The largest Microbot Medical seller in Q3 2022 was Renaissance Technologies, an estimated $5.14K sold.

Based on aggregated 13F filings for Q3 2022.